SCM Lifescience Co., Ltd.

Equities

A298060

KR7298060005

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-12 pm EDT			5-day change	1st Jan Change
2,855 ^KRW	+2.15%		-0.17%	-24.47%

2023	SCM Lifescience Co., Ltd.(KOSDAQ:A298060) dropped from S&P Global BMI Index	CI
2023	SCM LifeScience to Raise 30.9 Billion Won via Share Issuance	MT

SCM Lifescience Co., Ltd. has completed an IPO in the amount of KRW 30.6 billion.

June 11, 2020 at 12:00 am EDT

SCM Lifescience Co., Ltd. has completed an IPO in the amount of KRW 30.6 billion. Security Name: Shares Security Type: Common Stock Securities Offered: 1,800,000 PriceRange: KRW 17000 Discount Per Security: KRW 850 Transaction Features: Sponsor Backed Offering

Latest news about SCM Lifescience Co., Ltd.

SCM Lifescience Co., Ltd.(KOSDAQ:A298060) dropped from S&P Global BMI Index	23-09-18	CI
SCM LifeScience to Raise 30.9 Billion Won via Share Issuance	23-06-11	MT
Scm Lifescience Co., Ltd. Appoints Song Sun-Uk as CEO	21-11-14	CI
Vita Therapeutics, Inc. announced that it has received $32 million in funding from Cambrian BioPharma, Inc., SCM Lifescience Co., Ltd., Early Light Ventures	21-06-22	CI
Vita Therapeutics, Inc. announced that it expects to receive $22.443036 million in funding	21-01-11	CI
SCM Lifescience Co., Ltd.(KOSDAQ:A298060) added to S&P Global BMI Index	20-12-21	CI
SCM Lifescience Co., Ltd. has completed an IPO in the amount of KRW 30.6 billion.	20-06-11	CI
SCM Lifescience Co., Ltd. has filed an IPO.	19-11-13	CI
Genexine Inc. and SCM Lifescience Co. completed the acquisition of substantially all of the assets of Argos Therapeutics Inc.	19-02-12	CI
Genexine Inc. and SCM Lifescience Co. entered into an asset purchase agreement to acquire substantially all of the assets of Argos Therapeutics Inc. for $11.3 million.	19-01-21	CI
SCM LIFESCIENCE Co., Ltd. announced that it has received KRW 5.5000032 billion in funding from Duopharma Biotech Berhad	18-12-30	CI
SCM LIFESCIENCE Co., Ltd. announced that it expects to receive KRW 5.5000032 billion in funding from CCM Duopharma Biotech Berhad	18-10-24	CI

Chart SCM Lifescience Co., Ltd.

Duration

Period

More charts

Company Profile

SCM Lifescience Co Ltd is a Korea-based company engaged in the research and development of medicines. The Company is engaged in the business of the development and production of cell therapy products, the agency testing of cell production and quality, adult stem cell consulting, cosmetics manufacturing, and hair growth protein manufacturing.

Sector

Biotechnology & Medical Research

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
SCM LIFESCIENCE CO., LTD.	-24.47%	41.77M
VERTEX PHARMACEUTICALS INCORPORATED	+5.66%	109B
REGENERON PHARMACEUTICALS, INC.	+11.23%	105B
ARGENX SE	-0.38%	22.25B
BIONTECH SE	-12.15%	22.09B
GENMAB A/S	-7.66%	18.68B
WUXI APPTEC CO., LTD.	-36.52%	17.58B
BEIGENE, LTD.	-10.09%	16.85B
NEUROCRINE BIOSCIENCES, INC.	+3.33%	13.76B
SAREPTA THERAPEUTICS, INC.	+36.58%	12.46B

Bio Therapeutic Drugs